This release is available in French.
August 31, 2010 On Thursday, August 26, the Canadian Institutes of Health Research (CIHR), in collaboration with the MS Society of Canada, convened a meeting of leading North American experts in multiple sclerosis (MS) to identify research priorities for Canada in this area. Today, at a press conference in Ottawa, CIHR President Dr. Alain Beaudet announced the outcomes of the discussions and shared the recommendations he has made to the Honourable Leona Aglukkaq, Minister of Health.
"There was unanimous agreement from the scientific experts that it is premature to support pan-Canadian clinical trials on the proposed "Liberation Procedure," said Dr. Beaudet. "There is an overwhelming lack of scientific evidence on the safety and efficacy of the procedure, or even that there is any link between blocked veins and MS."
"The MS Society of Canada is a leading funder of MS research, so it was important for us to attend the August 26 meeting," said Yves Savoie, CEO and President of the MS Society of Canada. "We and the US National MS Society committed $2.4 million last June to support seven research teams to focus on chronic cerebrospinal venous insufficiency (CCSVI) and its relationship to MS. We firmly believe the studies currently under way are critical to advance understanding in this area of MS research." (MS Society news release, June 11, 2010: http://mssociety.ca/en/releases/nr_20100611.htm)
Dr. Beaudet has made the following three recommendations to the Minister of Health:
|Contact: CIHR Media Relations|
Canadian Institutes of Health Research